bioQuad Recalls Two Lots of OsteoDenx Supplement Capsules Over Undeclared Milk
bioQuad Life Sciences, based in Yorba Linda, California, is recalling two lots of its OsteoDenx dietary supplement capsules because they contain milk that was not declared on the label. The U.S. Food and Drug Administration (FDA) posted the recall announcement on November 13.
According to the notice, the problem surfaced during a routine FDA inspection: the lactoferrin in OsteoDenx is derived from milk, but the label does not declare milk, a major food allergen. Consumers with a milk allergy who eat the product risk a serious or life-threatening allergic reaction. The recalled capsules were sold between November 1, 2024 and November 11, 2026 through bioquad.com, Amazon and distributors, and were also sold at a dental office in Redwood City.
No illnesses related to the product had been reported as of the announcement, and distribution has been halted. The FDA advises consumers with a milk allergy not to consume the recalled lots and to dispose of or return the product as described in the notice, and to seek medical care if allergic symptoms occur.
(Source: U.S. Food and Drug Administration)
Source: U.S. Food and Drug Administration
Published by GSM · USA (original Chinese edition)
Photo: Wikimedia Commons：File:Omega 3 capsules in white bottle (52715127894).jpg（开放授权）
